Robert W. Carlson, MD, has been named Chief Executive Officer of the National Comprehensive Cancer Center.  
           
The University of Michigan (U-M) Comprehensive Cancer Center has appointed Kathleen A. Cooney, MD, to a new position as Deputy Director for Clinical Services. Dr. Cooney is the Frances and Victor Ginsberg Professor of Hematology/Oncology and Chief of the Division of Hematology/Oncology at the U-M Medical School.
       
Lisa M. DeAngelis, MD, Chair of Memorial Sloan-Kettering's Department of Neurology and Co-Executive Director of the Brain Tumor Center, has been elected to the Institute of Medicine. 
           
Hematology/oncology expert Richard I. Fisher, MD, has been named Interim Cancer Center Director and Physician-in-Chief of Fox Chase Cancer Center, now part of the Temple University Health System. Dr. Fisher has also been appointed Senior Associate Dean of Temple University School of Medicine.
           
The Herbert Irving Comprehensive Cancer Center at New York–Presbyterian Hospital/Columbia University Medical Center has welcomed the following ASCO members as new clinician-scientists specializing in leukemia: Mark G. Frattini, MD, PhD; Mark L. Heaney, MD, PhD; Joseph G. Jurcic, MD; and Nicole Lamanna, MD.
           
The inaugural holders of the Carol and Louis Della Penna Chair in Urologic Oncology and the Louis Della Penna Family Chair in Head and Neck Oncology at the Fox Chase Cancer Center are Richard E. Greenberg, MD, Chief of Urologic Oncology, and John A. "Drew" Ridge, MD, PhD, Chief of Head and Neck Surgery.
     
Mark R. Kelley, PhD, the Betty and Earl Herr Professor of Pediatric Oncology Research at the Indiana University Melvin and Bren Simon Cancer Center, is one of two researchers who has been awarded a multi-year, $3.2 million grant from the National Cancer Institute to develop and improve therapies for pancreatic cancer

          
Pierre P. Massion, MD, Associate Professor of Medicine and Cancer Biology, has been named Director of the Thoracic Program at Vanderbilt–Ingram Cancer Center.
           
Marcus A. Neubauer, MD, has accepted the position of Medical Director, Oncology Services for McKesson Specialty Health, in Seattle, WA. Dr. Neubauer will serve as a liaison between the US Oncology Network and the National Comprehensive Cancer Network.
             
Paul Sabbatini, MD, has been named to the new position of Deputy Physician-in-Chief for Clinical Research at Memorial Sloan-Kettering Cancer Center.    
             
Michel Sadelain, MD, PhD, of Memorial Sloan-Kettering Cancer Center, was a recipient of the 2012 William B. Coley Award for Distinguished Research in Tumor Immunology.     
             
Gary K. Schwartz, MD, of Memorial Sloan-Kettering Cancer Center, is the Principal Investigator for “Therapeutic Targeting of IDH1 and IDH2 Mutations in Acute Myeloid Leukemia (AML) and Chondrosarcoma”—one of five research teams that have been awarded $5 million in grants by the Starr Cancer Consortium. Co-principal investigators on this study include Ross L. Levine, MD, of Memorial Sloan-Kettering and Ari Melnick, MD, of Weill Cornell.             
             
Charles L. Sawyers, MD, Chair of Memorial Sloan-Kettering Cancer Center’s Human Oncology and Pathogenesis Program, is one of 11 awardees to receive the inaugural Breakthrough Prize in Life Sciences. Each of the recipients will receive $3 million. Dr Sawyers is also the recipient of ASCO’s 2013 Science of Oncology Award.     
             
A study published March 2013 in The Oncologist, led by ASCO President Sandra M. Swain, MD, FACP, Medical Director of the Washing Cancer Institute at MedStar Washington Hospital Center, found that a recent FDA-approved combination of therapies used to target HER2-positive breast cancer does not lead to increased cardiac problems for patients, but doctors should regularly perform cardiac monitoring on patients until additional long-term cardiac safety data become available.     
             
Anas Younes, MD, has been named Chief of the Lymphoma Service in the Division of Hematologic Oncology, Department of Medicine, at Memorial Sloan-Kettering Cancer Center.     

Please send your submissions for Member News & Networking to ascoconnection@asco.org.

In Memoriam

Stanley E. Order, MD
Glenn Norman Smith, MD
John Owen Clune, MD
Joseph F. Paone, MD, FACS
Jane C. Wright, MD
Kenneth A. Dressler, MD
Brent F. G. Treiger, MD

New Associate Editor Joins JCO
Joel E. Tepper, MD, a radiation oncologist with expertise in gastrointestinal cancers, was named an Associate Editor of the Journal of Clinical Oncology (JCO). Dr. Tepper is the Hector McLean Distinguished Professor of Cancer Research at the Carolina Center of Cancer Nanotechnology Excellence at the University of North Carolina at Chapel Hill.
 

New Editor-in-Chief Announced for Cancer.Net

Cancer.Net is proud to announce medical oncologist Robert S. Miller, MD, FACP, as the new Editor-in-Chief. Dr. Miller is an Assistant Professor of Oncology at the Johns Hopkins University School of Medicine and an Oncology Medical Information Officer at the Sidney Kimmel Comprehensive Cancer Center. He serves on the Editorial Board of the Journal of Oncology Practice and previously served as an Associate Editor for Cancer.Net. He is also a columnist on ASCOconnection.org. Look for a full interview with Dr. Miller in the ASCO Connection September Issue.